Results 231 to 240 of about 1,716,154 (283)

Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domains. [PDF]

Nat Immunol
Frazee CS, Chen S, Berry CT, Lee CS, Banciella RA, Ngo L, Shon D, Herman PJ, Fischman JS, Leff CL, Chen A, Kuo Y, Shestov AA, Kelly AR, Valentic B, Milone MC, O'Connor RS, Ellebrecht CT.   +17 more
europepmc   +1 more source

Sex-based disparities in cardiovascular outcomes: real-world evidence following chimeric antigen receptor T-cell therapy. [PDF]

Front Cardiovasc Med
Bahar AR, Bahar Y, Kaur P, Yalavarthi N, Awad A, Raheem S, Oktay AA.   +6 more
europepmc   +1 more source

A Feeder Cell-Free System for Chimeric Antigen Receptor Gene Transduction Into Natural Killer Cells. [PDF]

Bio Protoc
Kubo N, Baba M, Suzuki Y, Kasahara Y, Hosokai R, Imamura M, Saitoh A, Imai C.   +7 more
europepmc   +1 more source

Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination. [PDF]

Nat Commun
Warmuth L, Dötsch S, Trebo M, Bellucci S, Engels S, Valdivia Manrique R, Moukarzel K, Schütz JM, Hammel M, Straub A, Wagner S, Hochholzer A, Salinno C, Seigner J, Zajc CU, Schmidt GP, Michael J, Nerreter T, Hudecek M, Traxlmayr MW, Casucci M, Riddell SR, Poltorak MP, Busch DH, D'Ippolito E.   +24 more
europepmc   +1 more source

Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma. [PDF]

Blood Cancer J
Sharp J, Bhatta S, Huang JJ, Thomas CJ, Elghawy O, Fitzgerald L, Reef D, Teferra A, Voorhees TJ, Gupta S, Grover NS, Barta SK, Shadman M, Epperla N.   +13 more
europepmc   +1 more source

Anti-CD19 chimeric antigen receptor T cells in Evans syndrome of systemic lupus erythematosus. [PDF]

Ann Hematol
Lang M, Peng L, Jiang N, Li M, Zhang Y, Zeng X, Zhou D.   +6 more
europepmc   +1 more source

CHIMERIC ANTIGEN RECEPTOR

, 2017
The present invention is directed to a nucleic acid molecule comprising a polynucleotide sequence encoding a chimeric antigen receptor comprising (a) an anti-CLEC14A binding domain, (b) a transmembrane domain and (c) an intracellular signalling domain ...
ONUOHA SHIMOBI, PULÉ MARTIN, THOMAS SIMON, CORDOBA SHAUN, KOKALAKI EVANGELIA   +4 more
core   +10 more sources

Some of the next articles are maybe not open access.

Related searches:

Chimeric antigen receptors

Nature Biotechnology, 2020
openaire   +2 more sources

Chimeric antigen receptors

Nature Biotechnology, 2022
openaire   +2 more sources